Marketing Strategy Biotechnology Pharmaceutical Industry Production Equipment Dealers – A Case Study on S Company

• Main Authors: Chin-Fong Chuang, 莊金鳳
• Other Authors: 林志鴻
• Format: Others
• Language: zh-TW
• Published: 2016
• Online Access: http://ndltd.ncl.edu.tw/handle/zqtmy2

碩士 === 淡江大學 === 國際企業學系碩士在職專班 === 104 === In this study, to Taiwan''s industrial structure and development trend of the medical technology in recent years, governments across the world will be the development of the biotech industry as an important national development goal, and Taiwan also plays an important role in this milestone, and has by law to promote and strengthen the biotechnology industry could flourish. In the situation of many businesses opportunities, how can we use complete marketing strategy to create more profits, so that enterprises can sustainable development. In this study, companies in the S objects to study the formation of S company business competitive strategy, using Lin and Pao (2004) proposed policy evaluation frame, through the company''s mission statement cases to 7S model for internal environmental assessment to the five forces model analysis of the industry environment and the use of the opportunities and threats PESTEL architecture overall assessment of their environmental impact, through internal environment, external environment for the whole industry and the overall analysis, investigate cases of agents forming elements of the marketing strategy, and how to perform and then reached the corporate mission. S companies in Taiwan biomedical agents, the agents how to face the rapidly changing and complex nature, the development of unique marketing strategy needs to be applied because of the market, by the most appropriate positive "policy expertise and exclusive agent" in execution to achieve "a technology leader in biotechnology pharmaceutical industry" under the mission statement Company S, a Taiwan biomedical agent, how to face the rapidly changing and complex nature to develop unique marketing strategy for needs of the market, by the most appropriate positive "policy expertise and exclusive agent" in execution to achieve "a technology leader in biotechnology pharmaceutical industry" under the mission statement.